KV acknowledges validity of Purdue patents; Receives limited license rights to all strengths of oxycodone controlled-release tablets ST. LOUIS...
Entity not core to Company's finished dose pharmaceutical business ST. LOUIS, June 3 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:...
AstraZeneca Plc (AZN) has lifted allocation limits for blood-pressure medicine Toprol XL that were put in place to ensure supply of the drug after...
Decree outlines path forward to resume manufacturing at KV facilities ST. LOUIS, March 2 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company...
AstraZeneca (AZN) has effectively filled the supply gap following a shortage in the generic version of its blood pressure medicine Toprol XL after...
The following chart is a selection of some first-quarter announcements of job cuts since the beginning of the year. Some numbers are estimates...
Layoffs result from recent challenges, effort to reduce costs ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company...
ST. LOUIS, Feb. 3 /PRNewswire/ -- Ther-Rx Corporation, a subsidiary of KV Pharmaceutical Company (NYSE:KVa/KVb), is issuing a voluntary...
Previously Issued Recall to Wholesale Level on Certain Products Expanded to Retail Level ST. LOUIS, Feb. 3 /PRNewswire/ -- ETHEX Corporation, a...
Teva Pharmaceutical Industries Ltd. (TEVA) paid $7 million to the Massachusetts Medicaid program to settle a False Claims Act case pending in...
Sets New Standard for Prescription Prenatal Vitamins ST. LOUIS, Dec. 17 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.